FFUTURE
Log in Register
🇺🇸 en-US
🇸🇦 Arabic · العربية🇧🇩 Bengali · বাংলা🇨🇳 Chinese (Simplified) · 简体中文🇹🇼 Chinese (Traditional) · 繁體中文🇳🇱 Dutch · Nederlands🇺🇸 English🇵🇭 Filipino🇫🇷 French · Français🇩🇪 German · Deutsch🇬🇷 Greek · Ελληνικά🇮🇱 Hebrew · עברית🇮🇳 Hindi · हिन्दी🇮🇩 Indonesian · Bahasa Indonesia🇮🇹 Italian · Italiano🇯🇵 Japanese · 日本語🇰🇭 Khmer · ខ្មែរ🇰🇷 Korean · 한국어🇲🇾 Malay · Bahasa Melayu🇮🇷 Persian · فارسی🇵🇱 Polish · Polski🇧🇷 Portuguese · Português🇷🇴 Romanian · Română🇷🇺 Russian · Русский🇪🇸 Spanish · Español🇰🇪 Swahili · Kiswahili🇹🇭 Thai · ไทย🇹🇷 Turkish · Türkçe🇺🇦 Ukrainian · Українська🇵🇰 Urdu · اردو🇻🇳 Vietnamese · Tiếng Việt
Content details

Alignment Healthcare downgraded at BofA after CMS Star Rating for MA contract

BofA Securities on Friday downgraded Alignment Healthcare (ALHC) to Neutral from Buy after CMS lowered its Star Rating for one of its major California Medicare Advantage contracts to 3.5 stars from 4.

The bank lowered its price target to $9 from $25 (~19% upside based on the Oct. 9 close).

BofA noted that Alignment Healthcare went from having all of its members in plans with at least 4 stars to just 25%. The important California contract, H3815, is responsible for 75% of the managed care company's MA membership.

As a result, the contracts with a rating of below 4 stars won't be eligible for bonus payment from CMS, which "potentially [makes] it more
difficult to expand profitably into new markets," analyst Kevin Fischbeck said.

"However, there is a potential silver lining, in that if the company can move up its star rating on that one contract, there will be a meaningful lift to profitability in 2029," he added. "We see this as real potential, but visibility remains low and the binary nature of the event likely means that the ALHC stock will trade at a discount to its historical average until we see improvement."

Alignment Healthcare closed down ~13%.